Saturday, December 13, 2025

Trade settlement between India, Malaysia now possible in Indian Rupee

Date:

New Delhi: Trade between India and Malaysia can now be settled in Indian Rupee (INR) in addition to the current modes of settlement in other currencies.

This follows the decision by the Reserve Bank of India in July 2022 to allow the settlement of international trade in the Indian Rupee (INR). This initiative by RBI aims to facilitate the growth of global trade and to support the interests of the global trading community in the Indian Rupee (INR).

Notably, India, among others, imports a large amount of palm oil and its derivatives from Malaysia to fulfil its huge domestic edible oil demand.

“India International Bank of Malaysia (IIBM), based in Kuala Lumpur, has operationalised this mechanism by opening a Special Rupee Vostro Account through its Corresponding Bank in India i.e., Union Bank of India,” an official statement said by the Ministry of External Affairs said on Saturday.

Meanwhile, India on Friday unveiled India’s new Foreign Trade Policy (FTP) 2023, which seeks to boost the country’s exports to USD 2 trillion by the year 2030 and especially focuses on international trade settlement in rupees.

ANI

Related articles

Dr. Amitav Banerjee’s Discussion on Weight Loss Drugs in India

Dr. (Prof) Amitav Banerjee is a globally recognized epidemiologist, public health expert, and the distinguished Chairman of the...

Chief Justice Suryakant Proposes Historic National Judicial Policy for Uniform and Predictable Justice Across India

In a landmark address delivered on Constitution Day, Chief Justice Suryakant has unveiled a bold proposal for a...

Universal Health Organisation (UHO) Weekly Newsletter – 28 November 2025

Face Saving Fake Covid Inquiry Report by UK: Setting the stage for Pandemic Treaty? Website: https://uho.org.in Download: https://uho.org.in/nl/2025-11-28-newsletter.pdf (copy and...

Dr. Lalit Kumar Anande Challenges Conventional Wisdom on Superbug Threat, Reveals Ancient Roots of Antibiotic Resistance

Dr. Lalit Kumar Anande, a leading voice in clinical research and public health, has issued a stark warning...